Table 1. Structure–activity relationship of C4 substituted bis-tetrahydrofuran protease inhibitors.
Compound Ligand number |
Ki (nM) |
IC50 (nM) |
|
---|---|---|---|
13 (TMC-126) |
0.014 | 1.4 | |
14 | 0.0029 | 2.4 | |
15 | 0.035 | 55 | |
16 | 0.073 | 335 | |
17 | 0.3 | ND |
Compound Ligand number |
Ki (nM) |
IC50 (nM) |
|
---|---|---|---|
13 (TMC-126) |
0.014 | 1.4 | |
14 | 0.0029 | 2.4 | |
15 | 0.035 | 55 | |
16 | 0.073 | 335 | |
17 | 0.3 | ND |